[
    [
        {
            "time": "2019-01-24",
            "original_text": "Sell-Side Issues Positive Prognosis For Abbott Following Mixed Q4 Results, Strong 2019 Outlook",
            "features": {
                "keywords": [
                    "positive prognosis",
                    "mixed Q4 results",
                    "strong 2019 outlook"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Sell-Side Issues Positive Prognosis For Abbott Following Mixed Q4 Results, Strong 2019 Outlook",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "FDA's warning could impact global market for cardiovascular devices",
            "features": {
                "keywords": [
                    "FDA warning",
                    "global market",
                    "cardiovascular devices"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "FDA's warning could impact global market for cardiovascular devices",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "Company News For Jan 24, 2019",
            "features": {
                "keywords": [],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Company News For Jan 24, 2019",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 4,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "JNJ or ABT: Which Company Returns Higher Shareholder Value?",
            "features": {
                "keywords": [
                    "JNJ",
                    "ABT",
                    "shareholder value"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "JNJ or ABT: Which Company Returns Higher Shareholder Value?",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "Abbott (ABT) Q4 Earnings Meet Estimates, Organic Growth Solid",
            "features": {
                "keywords": [
                    "Q4 earnings",
                    "meet estimates",
                    "organic growth solid"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Abbott (ABT) Q4 Earnings Meet Estimates, Organic Growth Solid",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "Abbott Labs (ABT) Stock Slips Despite Solid Q4 Earnings",
            "features": {
                "keywords": [
                    "stock slips",
                    "solid Q4 earnings"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Abbott Labs (ABT) Stock Slips Despite Solid Q4 Earnings",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "5 Must-See Stock Charts for Thursday: ABT, IBM, SBUX, PZZA",
            "features": {
                "keywords": [
                    "must-see stock charts",
                    "ABT",
                    "IBM",
                    "SBUX",
                    "PZZA"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "technology",
                    "consumer goods"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "5 Must-See Stock Charts for Thursday: ABT, IBM, SBUX, PZZA",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-23",
            "original_text": "Hedge Fund Hooligans: Cramer's 'Mad Money' Recap (Wednesday 1/23/19)",
            "features": {
                "keywords": [
                    "hedge fund",
                    "Cramer",
                    "Mad Money"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Hedge Fund Hooligans: Cramer's 'Mad Money' Recap (Wednesday 1/23/19)",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]